Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/19843

TDMS Study 88138-03 Pathology Tables

NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03
Route: DOSED FEED                                                                                                 Time: 15:17:01

                                                         FINAL #1 RATS




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  119-61-9

       Lock Date:  04/26/02

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                16           10            9           13                                     
    Natural Death                                      2            2            4            3                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                32           38           37           34                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)         (50)                                   
      Inflammation                                                  1 (2%)                                                          
      Periesophageal Tissue, Necrosis, Fatty                        1 (2%)                                                          
   Intestine Large, Colon                             (50)         (50)         (50)         (50)                                   
      Inflammation                                     1 (2%)                                                                       
      Metaplasia, Mucous                               1 (2%)                                                                       
      Parasite Metazoan                                1 (2%)       3 (6%)       2 (4%)       3 (6%)                                
   Intestine Large, Rectum                            (50)         (50)         (50)         (50)                                   
      Parasite Metazoan                                8 (16%)      8 (16%)     14 (28%)      6 (12%)                               
      Ulcer                                                         1 (2%)                                                          
   Intestine Large, Cecum                             (50)         (50)         (50)         (50)                                   
      Inflammation                                                  1 (2%)                                                          
      Mineralization                                                             1 (2%)                                             
   Intestine Small, Duodenum                          (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                                             1 (2%)                                
   Intestine Small, Jejunum                           (50)         (50)         (50)         (50)                                   
      Inflammation                                                  1 (2%)       2 (4%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      2 (4%)       2 (4%)       5 (10%)      1 (2%)                                
      Basophilic Focus                                48 (96%)     48 (96%)     41 (82%)     43 (86%)                               
      Clear Cell Focus                                15 (30%)     13 (26%)     10 (20%)     10 (20%)                               
      Degeneration, Cystic                             1 (2%)                    3 (6%)       4 (8%)                                
      Eosinophilic Focus                                            6 (12%)      6 (12%)      9 (18%)                               
      Fatty Change, Diffuse                           11 (22%)      8 (16%)      9 (18%)     20 (40%)                               
      Fibrosis                                                                                1 (2%)                                
      Hematopoietic Cell Proliferation                 1 (2%)       6 (12%)      4 (8%)       2 (4%)                                
      Hepatodiaphragmatic Nodule                       5 (10%)      6 (12%)      6 (12%)      6 (12%)                               
      Inflammation, Chronic Active                    46 (92%)     38 (76%)     29 (58%)     30 (60%)                               
      Mixed Cell Focus                                10 (20%)     11 (22%)      5 (10%)      5 (10%)                               
      Necrosis                                        12 (24%)      6 (12%)     11 (22%)     12 (24%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Bile Duct, Cyst                                                                         1 (2%)                                
      Bile Duct, Hyperplasia                          10 (20%)     35 (70%)     39 (78%)     40 (80%)                               
      Hepatocyte, Centrilobular, Hypertrophy                       27 (54%)     30 (60%)     33 (66%)                               
      Oval Cell, Hyperplasia                                                                  3 (6%)                                
   Mesentery                                          (12)         (18)         (10)         (6)                                    
      Fat, Necrosis                                   11 (92%)     18 (100%)    10 (100%)     4 (67%)                               
   Oral Mucosa                                        (4)          (8)          (4)          (4)                                    
      Hyperplasia, Squamous                                                                   1 (25%)                               
      Gingival, Inflammation                           4 (100%)     7 (88%)      4 (100%)     4 (100%)                              
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Basophilic Focus                                                           1 (2%)       1 (2%)                                
      Inflammation                                    12 (24%)      3 (6%)       2 (4%)       6 (12%)                               
      Acinus, Atrophy                                 17 (34%)     10 (20%)     11 (22%)     12 (24%)                               
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                          2 (4%)                    1 (2%)       1 (2%)                                
      Basophilic Focus                                 1 (2%)                    1 (2%)                                             
      Inflammation                                                               1 (2%)                                             
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Hyperplasia, Squamous                            2 (4%)       2 (4%)       2 (4%)       4 (8%)                                
      Inflammation                                     4 (8%)       2 (4%)       2 (4%)       3 (6%)                                
      Ulcer                                                         1 (2%)       1 (2%)       2 (4%)                                
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Erosion                                                       1 (2%)       1 (2%)       1 (2%)                                
      Inflammation                                                               2 (4%)       3 (6%)                                
      Mineralization                                                2 (4%)       2 (4%)                                             
      Ulcer                                            1 (2%)                                 1 (2%)                                
      Epithelium, Atrophy                                                        1 (2%)                                             
   Tooth                                                                        (3)          (3)                                    
      Inflammation                                                               3 (100%)     2 (67%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (50)         (50)                                   
      Mineralization                                                                          1 (2%)                                
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  46 (92%)     46 (92%)     48 (96%)     46 (92%)                               
      Atrium, Thrombosis                                            1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Angiectasis                                     42 (84%)     36 (72%)     18 (36%)     24 (48%)                               
      Atrophy                                          1 (2%)                                 1 (2%)                                
      Degeneration, Cystic                             3 (6%)       2 (4%)       2 (4%)                                             
      Hematopoietic Cell Proliferation                 3 (6%)       1 (2%)       2 (4%)       2 (4%)                                
      Hyperplasia                                      6 (12%)     10 (20%)      6 (12%)      6 (12%)                               
      Hypertrophy                                      7 (14%)      5 (10%)      5 (10%)      8 (16%)                               
      Karyomegaly                                      1 (2%)                                                                       
      Necrosis                                         5 (10%)      7 (14%)      5 (10%)      2 (4%)                                
      Vacuolization Cytoplasmic                       14 (28%)     16 (32%)     15 (30%)     20 (40%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                   1 (2%)       2 (4%)                                             
      Necrosis                                         2 (4%)                                                                       
      Vacuolization Cytoplasmic                        1 (2%)                                                                       
   Parathyroid Gland                                  (47)         (48)         (44)         (48)                                   
      Hyperplasia                                                   1 (2%)                    1 (2%)                                
   Pituitary Gland                                    (50)         (50)         (50)         (50)                                   
      Angiectasis                                     30 (60%)     30 (60%)     23 (46%)     23 (46%)                               
      Cyst                                             2 (4%)       1 (2%)       1 (2%)       2 (4%)                                
      Hyperplasia                                     23 (46%)     24 (48%)     20 (40%)     18 (36%)                               
      Inflammation                                     1 (2%)                                                                       
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      C-Cell, Hyperplasia                             34 (68%)     11 (22%)     13 (26%)      8 (16%)                               
      Follicle, Cyst                                   1 (2%)                    1 (2%)       1 (2%)                                
      Follicle, Hyperplasia                                         2 (4%)                                                          
      Follicular Cell, Hyperplasia                                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (50)         (50)         (50)         (50)                                   
      Atrophy                                                                    1 (2%)                                             
      Cyst                                             3 (6%)       2 (4%)       1 (2%)                                             
      Hyperplasia                                      6 (12%)      1 (2%)       2 (4%)                                             
      Hyperplasia, Squamous                                                                   1 (2%)                                
      Inflammation                                     2 (4%)       2 (4%)       2 (4%)                                             
      Metaplasia, Squamous                             1 (2%)                                                                       
   Ovary                                              (50)         (50)         (50)         (50)                                   
      Cyst                                             6 (12%)     13 (26%)     10 (20%)      9 (18%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Interstitial Cell, Hyperplasia                                1 (2%)                                                          
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Angiectasis, Focal                                                                      1 (2%)                                
      Inflammation                                                                            1 (2%)                                
      Cervix, Hypertrophy                                                                     1 (2%)                                
      Endometrium, Hyperplasia, Cystic                12 (24%)     20 (40%)     20 (40%)     20 (40%)                               
      Endometrium, Hyperplasia, Adenomatous            1 (2%)       1 (2%)                    1 (2%)                                
      Serosa, Inflammation, Granulomatous                           2 (4%)                                                          
   Vagina                                                          (1)          (1)                                                 
      Inflammation                                                               1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Inflammation, Granulomatous                      1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Myelofibrosis                                    2 (4%)                    2 (4%)       6 (12%)                               
      Necrosis                                                                   1 (2%)       1 (2%)                                
      Erythroid Cell, Hyperplasia                      8 (16%)      6 (12%)      7 (14%)      2 (4%)                                
      Myeloid Cell, Hyperplasia                       11 (22%)     13 (26%)     20 (40%)     13 (26%)                               
   Lymph Node                                         (8)          (8)          (11)         (12)                                   
      Axillary, Right, Ectasia                                                   1 (9%)                                             
      Axillary, Right, Infiltration Cellular,                                                                                       
        Plasma Cell                                                              1 (9%)                                             
      Deep Cervical, Ectasia                           1 (13%)                                                                      
      Deep Cervical, Hemorrhage                        1 (13%)                                                                      
      Deep Cervical, Infiltration Cellular, Plasma                                                                                  
        Cell                                           3 (38%)                                2 (17%)                               
      Deep Cervical, Infiltration Cellular,                                                                                         
        Histiocyte                                     3 (38%)                                                                      
      Mediastinal, Hemorrhage                                                                 2 (17%)                               
      Mediastinal, Infiltration Cellular, Plasma                                                                                    
        Cell                                           2 (25%)      1 (13%)      4 (36%)      2 (17%)                               
      Mediastinal, Infiltration Cellular,                                                                                           
        Histiocyte                                                               1 (9%)       1 (8%)                                
      Pancreatic, Hemorrhage                                        2 (25%)                                                         
      Pancreatic, Infiltration Cellular, Histiocyte                 3 (38%)                   1 (8%)                                
      Pancreatic, Pigmentation, Hemosiderin                         2 (25%)                                                         
      Renal, Infiltration Cellular, Histiocyte                      1 (13%)                   1 (8%)                                
      Renal, Pigmentation                                                                     1 (8%)                                
   Lymph Node, Mesenteric                             (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Plasma Cell                            1 (2%)       1 (2%)       2 (4%)                                
      Infiltration Cellular, Histiocyte               50 (100%)    49 (98%)     48 (96%)     49 (98%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Spleen                                             (49)         (50)         (50)         (50)                                   
      Accessory Spleen                                                           1 (2%)       1 (2%)                                
      Autolysis                                                                  2 (4%)                                             
      Fibrosis                                         1 (2%)                                 1 (2%)                                
      Hematopoietic Cell Proliferation                47 (96%)     45 (90%)     40 (80%)     45 (90%)                               
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)       2 (4%)                                
      Infarct                                          1 (2%)                                                                       
      Inflammation, Granulomatous                      1 (2%)       1 (2%)                                                          
      Pigmentation, Hemosiderin                       48 (98%)     50 (100%)    49 (98%)     49 (98%)                               
      Lymphoid Follicle, Atrophy                                    5 (10%)                                                         
      Red Pulp, Hyperplasia                                                                   1 (2%)                                
   Thymus                                             (50)         (49)         (46)         (50)                                   
      Atrophy                                         49 (98%)     48 (98%)     44 (96%)     49 (98%)                               
      Cyst                                                                                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (50)                                   
      Atrophy                                                                                 1 (2%)                                
      Galactocele                                      7 (14%)      3 (6%)       2 (4%)       2 (4%)                                
      Hyperplasia                                      3 (6%)       4 (8%)       1 (2%)       3 (6%)                                
      Inflammation                                     1 (2%)       1 (2%)       1 (2%)                                             
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                                  1 (2%)       1 (2%)                                
      Sebaceous Gland, Hyperplasia                                                            1 (2%)                                
      Subcutaneous Tissue, Necrosis                                              1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                                                                  2 (4%)                                
   Skeletal Muscle                                    (1)          (1)          (3)          (1)                                    
      Inflammation                                     1 (100%)     1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Gliosis                                                                    1 (2%)                                             
      Hemorrhage                                       2 (4%)       1 (2%)       2 (4%)                                             
      Hydrocephalus                                    1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
NERVOUS SYSTEM - CONT                                                                                                               
      Inflammation                                     1 (2%)       1 (2%)       1 (2%)                                             
      Mineralization                                   1 (2%)                                                                       
      Necrosis                                                      1 (2%)       1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Acute                                           2 (4%)       1 (2%)                                             
      Inflammation, Granulomatous                     12 (24%)      5 (10%)      9 (18%)      7 (14%)                               
      Metaplasia, Squamous                                                       1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                18 (36%)     18 (36%)     13 (26%)     15 (30%)                               
      Alveolus, Infiltration Cellular, Histiocyte     50 (100%)    50 (100%)    50 (100%)    50 (100%)                              
      Interstitium, Fibrosis                                                     1 (2%)                                             
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation                                     2 (4%)       1 (2%)       3 (6%)       1 (2%)                                
      Thrombosis                                                                 2 (4%)                                             
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Inflammation                                                  4 (8%)       2 (4%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (50)         (50)         (50)         (50)                                   
      Inflammation                                     1 (2%)       1 (2%)       2 (4%)       1 (2%)                                
      Lens, Cataract                                   1 (2%)       1 (2%)       2 (4%)       2 (4%)                                
      Optic Nerve, Fibrosis                                                                   1 (2%)                                
      Retina, Degeneration                             2 (4%)       2 (4%)       4 (8%)       4 (8%)                                
      Retina, Dysplasia                                             1 (2%)                                                          
   Harderian Gland                                    (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphoid                 14 (28%)     10 (20%)      6 (12%)      9 (18%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Accumulation, Hyaline Droplet                                              2 (4%)       1 (2%)                                
      Fibrosis                                         1 (2%)                                                                       
      Infarct                                                       1 (2%)       2 (4%)       1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Nephropathy                                     47 (94%)     49 (98%)     48 (96%)     49 (98%)                               
      Cortex, Inflammation                                                                    1 (2%)                                
      Cortex, Mineralization                           2 (4%)       1 (2%)       4 (8%)       1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Medulla, Fibrosis                                1 (2%)                                                                       
      Medulla, Mineralization                         43 (86%)     49 (98%)     49 (98%)     46 (92%)                               
      Pelvis, Inflammation                             1 (2%)                    4 (8%)       2 (4%)                                
      Pelvis, Transitional Epithelium, Hyperplasia     1 (2%)       2 (4%)       2 (4%)       4 (8%)                                
      Renal Tubule, Cyst                                                                      1 (2%)                                
      Renal Tubule, Hyperplasia                                     1 (2%)       1 (2%)       1 (2%)                                
      Renal Tubule, Pigmentation                                                              1 (2%)                                
      Renal Tubule, Vacuolization Cytoplasmic                       1 (2%)                                                          
   Urinary Bladder                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                   1 (2%)       1 (2%)                                             
      Inflammation                                     1 (2%)       1 (2%)                                                          
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                25           12           16           44                                     
    Natural Death                                      3           11            3            4                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                22           27           31            2                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (50)         (50)         (50)         (50)                                   
      Erosion                                                                    1 (2%)                                             
      Inflammation                                                               1 (2%)                                             
      Parasite Metazoan                                1 (2%)       1 (2%)       1 (2%)                                             
   Intestine Large, Rectum                            (50)         (50)         (50)         (50)                                   
      Parasite Metazoan                                6 (12%)      6 (12%)      8 (16%)      5 (10%)                               
   Intestine Large, Cecum                             (50)         (50)         (50)         (50)                                   
      Erosion                                          1 (2%)                    1 (2%)       1 (2%)                                
      Inflammation                                                                            4 (8%)                                
      Mineralization                                                                          2 (4%)                                
      Ulcer                                                                                   1 (2%)                                
   Intestine Small, Duodenum                          (50)         (50)         (50)         (50)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                          1 (2%)                                                          
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Basophilic Focus                                24 (48%)     25 (50%)     32 (64%)     19 (38%)                               
      Clear Cell Focus                                19 (38%)     19 (38%)     18 (36%)                                            
      Congestion                                       1 (2%)                                                                       
      Degeneration, Cystic                             8 (16%)     11 (22%)     20 (40%)     15 (30%)                               
      Eosinophilic Focus                               5 (10%)     14 (28%)     10 (20%)      9 (18%)                               
      Fatty Change, Diffuse                           22 (44%)     20 (40%)     22 (44%)     15 (30%)                               
      Hematopoietic Cell Proliferation                 4 (8%)       1 (2%)       2 (4%)       4 (8%)                                
      Hepatodiaphragmatic Nodule                       2 (4%)       6 (12%)      1 (2%)       1 (2%)                                
      Infarct                                                                                 1 (2%)                                
      Inflammation, Chronic Active                    22 (44%)     21 (42%)     35 (70%)     33 (66%)                               
      Inflammation, Granulomatous                      1 (2%)                                 2 (4%)                                
      Mineralization                                                                          1 (2%)                                
      Mixed Cell Focus                                 9 (18%)     17 (34%)     22 (44%)      4 (8%)                                
      Necrosis                                        19 (38%)     19 (38%)      9 (18%)     14 (28%)                               
      Bile Duct, Cyst                                               1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Bile Duct, Hyperplasia                          49 (98%)     46 (92%)     48 (96%)     50 (100%)                              
      Hepatocyte, Multinucleated                       1 (2%)                    1 (2%)                                             
      Hepatocyte, Centrilobular, Hypertrophy                       17 (34%)     31 (62%)     19 (38%)                               
      Hepatocyte, Centrilobular, Necrosis                                                     1 (2%)                                
      Vein, Inflammation                                                                      1 (2%)                                
   Mesentery                                          (9)          (12)         (8)          (4)                                    
      Inflammation                                     1 (11%)                   1 (13%)      1 (25%)                               
      Fat, Necrosis                                    7 (78%)      7 (58%)      7 (88%)      3 (75%)                               
   Oral Mucosa                                        (8)          (8)          (5)          (7)                                    
      Gingival, Hyperplasia                                                      1 (20%)                                            
      Gingival, Inflammation                           8 (100%)     6 (75%)      5 (100%)     5 (71%)                               
      Pharyngeal, Inflammation                                                                1 (14%)                               
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Basophilic Focus                                              1 (2%)                                                          
      Cyst                                                                                    3 (6%)                                
      Inflammation                                    14 (28%)     16 (32%)      6 (12%)      9 (18%)                               
      Metaplasia, Hepatocyte                                                                  1 (2%)                                
      Acinus, Atrophy                                 20 (40%)     21 (42%)     22 (44%)     10 (20%)                               
      Acinus, Hyperplasia                              1 (2%)                                                                       
   Salivary Glands                                    (49)         (50)         (50)         (49)                                   
      Atrophy                                          1 (2%)       1 (2%)       3 (6%)                                             
      Inflammation                                                  2 (4%)                                                          
   Stomach, Forestomach                               (50)         (49)         (49)         (50)                                   
      Autolysis                                                     1 (2%)                                                          
      Hyperplasia, Squamous                            7 (14%)      4 (8%)      10 (20%)     17 (34%)                               
      Inflammation                                     8 (16%)      6 (12%)      8 (16%)     12 (24%)                               
      Mineralization                                                1 (2%)       1 (2%)       3 (6%)                                
      Ulcer                                            4 (8%)       1 (2%)       8 (16%)      8 (16%)                               
   Stomach, Glandular                                 (50)         (50)         (49)         (50)                                   
      Erosion                                          5 (10%)      2 (4%)       3 (6%)       3 (6%)                                
      Hyperplasia                                                                1 (2%)                                             
      Inflammation                                     5 (10%)      5 (10%)      4 (8%)       7 (14%)                               
      Mineralization                                                             5 (10%)     15 (30%)                               
      Ulcer                                            1 (2%)                    1 (2%)       4 (8%)                                
   Tooth                                              (3)          (5)          (2)          (3)                                    
      Inflammation                                     1 (33%)                   1 (50%)      1 (33%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (50)         (50)                                   
      Inflammation                                                               1 (2%)                                             
      Mineralization                                                1 (2%)       1 (2%)      11 (22%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Pulmonary Artery, Pulmonary Vein, Hypertrophy                              1 (2%)                                             
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  48 (96%)     48 (96%)     47 (94%)     49 (98%)                               
      Mineralization                                                             2 (4%)       6 (12%)                               
      Aorta, Tunic, Media, Mineralization                           1 (2%)                                                          
      Atrium, Thrombosis                               3 (6%)       5 (10%)      2 (4%)       1 (2%)                                
      Endocardium, Hyperplasia                                      2 (4%)                                                          
      Valve, Thrombosis                                             1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (49)         (50)         (50)                                   
      Angiectasis                                      4 (8%)       4 (8%)       2 (4%)       1 (2%)                                
      Atrophy                                                       1 (2%)                                                          
      Cytoplasmic Alteration                           1 (2%)                                                                       
      Degeneration, Cystic                             1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 5 (10%)                   2 (4%)                                             
      Hyperplasia                                      1 (2%)       4 (8%)      11 (22%)      4 (8%)                                
      Hypertrophy                                      8 (16%)      2 (4%)       3 (6%)       3 (6%)                                
      Necrosis                                         1 (2%)       4 (8%)                    1 (2%)                                
      Vacuolization Cytoplasmic                       27 (54%)     27 (55%)     31 (62%)     27 (54%)                               
   Adrenal Medulla                                    (50)         (49)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Hyperplasia                                      6 (12%)      8 (16%)     11 (22%)      5 (10%)                               
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)                                                                       
   Parathyroid Gland                                  (49)         (45)         (48)         (49)                                   
      Hyperplasia                                      2 (4%)       1 (2%)      19 (40%)     32 (65%)                               
   Pituitary Gland                                    (50)         (50)         (50)         (50)                                   
      Angiectasis                                      4 (8%)      10 (20%)     11 (22%)      3 (6%)                                
      Cyst                                             6 (12%)      3 (6%)       1 (2%)       5 (10%)                               
      Hyperplasia                                     16 (32%)     21 (42%)     12 (24%)     13 (26%)                               
      Inflammation                                                  1 (2%)                    1 (2%)                                
      Pigmentation, Hemosiderin                                     1 (2%)                                                          
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Mononuclear Cell          1 (2%)                                                                       
      Ultimobranchial Cyst                                                       2 (4%)       1 (2%)                                
      C-Cell, Hyperplasia                             17 (34%)      8 (16%)      8 (16%)      5 (10%)                               
      Follicle, Cyst                                                1 (2%)                                                          
      Follicle, Degeneration                           1 (2%)       2 (4%)                                                          
      Follicular Cell, Hyperplasia                                  1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Granuloma Sperm                                  1 (2%)                    1 (2%)       2 (4%)                                
      Inflammation                                     3 (6%)                    4 (8%)       1 (2%)                                
   Preputial Gland                                    (50)         (50)         (50)         (49)                                   
      Atrophy                                                                    1 (2%)                                             
      Hyperplasia                                      1 (2%)       1 (2%)                    1 (2%)                                
      Inflammation                                     2 (4%)       2 (4%)       1 (2%)       1 (2%)                                
      Duct, Cyst                                                                 1 (2%)       1 (2%)                                
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Atrophy                                          4 (8%)       7 (14%)      8 (16%)      4 (8%)                                
      Hyperplasia                                      2 (4%)       3 (6%)       4 (8%)                                             
      Inflammation                                    18 (36%)     17 (34%)     26 (52%)     26 (52%)                               
   Seminal Vesicle                                    (50)         (50)         (50)         (49)                                   
      Atrophy                                          3 (6%)       7 (14%)      8 (16%)      4 (8%)                                
      Inflammation                                     1 (2%)                    1 (2%)       1 (2%)                                
      Mineralization                                                                          4 (8%)                                
   Testes                                             (50)         (50)         (50)         (50)                                   
      Inflammation                                                  1 (2%)                    1 (2%)                                
      Necrosis                                                      2 (4%)                                                          
      Germinal Epithelium, Degeneration                6 (12%)      5 (10%)      6 (12%)      7 (14%)                               
      Interstitial Cell, Hyperplasia                  15 (30%)     12 (24%)     14 (28%)     22 (44%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (49)         (50)         (50)                                   
      Hyperplasia, Megakaryocyte                                    1 (2%)                                                          
      Inflammation, Granulomatous                                                1 (2%)       2 (4%)                                
      Myelofibrosis                                                 1 (2%)       2 (4%)       2 (4%)                                
      Necrosis                                                      1 (2%)                                                          
      Erythroid Cell, Hyperplasia                     13 (26%)      3 (6%)      10 (20%)     10 (20%)                               
      Myeloid Cell, Hyperplasia                       21 (42%)     27 (55%)     20 (40%)     14 (28%)                               
   Lymph Node                                         (19)         (20)         (16)         (19)                                   
      Deep Cervical, Ectasia                           2 (11%)                                1 (5%)                                
      Deep Cervical, Infiltration Cellular, Plasma                                                                                  
        Cell                                           1 (5%)       2 (10%)                   2 (11%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Mediastinal, Ectasia                             3 (16%)                   4 (25%)      3 (16%)                               
      Mediastinal, Hemorrhage                          1 (5%)                    1 (6%)       2 (11%)                               
      Mediastinal, Hyperplasia                                                   1 (6%)       2 (11%)                               
      Mediastinal, Infiltration Cellular, Plasma                                                                                    
        Cell                                                        1 (5%)       2 (13%)      3 (16%)                               
      Mediastinal, Infiltration Cellular,                                                                                           
        Histiocyte                                     2 (11%)                                                                      
      Mediastinal, Inflammation                                                  1 (6%)                                             
      Pancreatic, Ectasia                                                        2 (13%)      2 (11%)                               
      Pancreatic, Hemorrhage                                                     1 (6%)       1 (5%)                                
      Pancreatic, Infiltration Cellular, Histiocyte    1 (5%)       1 (5%)       2 (13%)                                            
      Pancreatic, Inflammation                                                   3 (19%)      1 (5%)                                
      Renal, Ectasia                                                                          1 (5%)                                
      Renal, Infiltration Cellular, Histiocyte                                                1 (5%)                                
   Lymph Node, Mandibular                             (5)          (1)          (2)                                                 
      Ectasia                                          1 (20%)                                                                      
   Lymph Node, Mesenteric                             (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                 6 (12%)                               
      Ectasia                                          4 (8%)       2 (4%)       5 (10%)      4 (8%)                                
      Infiltration Cellular, Histiocyte               47 (94%)     41 (82%)     48 (96%)     46 (92%)                               
      Inflammation                                     1 (2%)                                                                       
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Accessory Spleen                                              1 (2%)                                                          
      Autolysis                                                     1 (2%)                                                          
      Fibrosis                                         1 (2%)                    3 (6%)       1 (2%)                                
      Hematopoietic Cell Proliferation                45 (90%)     42 (84%)     45 (90%)     41 (82%)                               
      Hemorrhage                                                                 1 (2%)       1 (2%)                                
      Hyperplasia, Lymphoid                            6 (12%)      2 (4%)       9 (18%)      4 (8%)                                
      Inflammation, Granulomatous                      1 (2%)       3 (6%)       7 (14%)      1 (2%)                                
      Necrosis                                         1 (2%)       2 (4%)                    1 (2%)                                
      Pigmentation, Hemosiderin                       39 (78%)     43 (86%)     44 (88%)     43 (86%)                               
      Lymphoid Follicle, Atrophy                       1 (2%)                    1 (2%)       2 (4%)                                
   Thymus                                             (48)         (48)         (48)         (48)                                   
      Atrophy                                         44 (92%)     42 (88%)     47 (98%)     46 (96%)                               
      Ectopic Parathyroid Gland                                     1 (2%)                    4 (8%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (48)         (50)         (50)                                   
      Fibrosis                                         1 (2%)                                                                       
      Galactocele                                      2 (4%)                    1 (2%)                                             
      Inflammation                                     1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   13                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
   Skin                                               (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation                                     2 (4%)                                                                       
      Subcutaneous Tissue, Inflammation                             1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                                                     1 (2%)       4 (8%)                                
      Osteosclerosis                                                             1 (2%)                                             
   Skeletal Muscle                                    (2)          (2)          (1)                                                 
      Degeneration                                     1 (50%)      1 (50%)      1 (100%)                                           
      Inflammation                                     1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       5 (10%)      5 (10%)      2 (4%)       5 (10%)                               
      Necrosis                                         2 (4%)       4 (8%)                                                          
   Peripheral Nerve                                   (1)                                                                           
      Infiltration Cellular, Mononuclear Cell          1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (49)         (50)         (50)                                   
      Inflammation, Acute                              2 (4%)       2 (4%)       5 (10%)      7 (14%)                               
      Inflammation, Granulomatous                      2 (4%)       4 (8%)       5 (10%)      2 (4%)                                
      Metaplasia, Squamous                                                                    1 (2%)                                
      Mineralization                                                             2 (4%)      10 (20%)                               
      Necrosis                                         1 (2%)                                                                       
      Thrombosis                                                    1 (2%)       1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                16 (32%)      5 (10%)     13 (26%)      7 (14%)                               
      Alveolus, Infiltration Cellular, Histiocyte     46 (92%)     47 (96%)     49 (98%)     50 (100%)                              
      Bronchiole, Hyperplasia                          1 (2%)       3 (6%)                                                          
      Interstitium, Fibrosis                                        2 (4%)                                                          
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation                                     7 (14%)      7 (14%)      8 (16%)      9 (18%)                               
      Thrombosis                                       1 (2%)       2 (4%)       1 (2%)                                             
      Olfactory Epithelium, Degeneration               1 (2%)                                                                       
      Olfactory Epithelium, Metaplasia                 1 (2%)                    1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   14                                                              
                                                                                                                                   
NTP Experiment-Test: 88138-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                            BENZOPHENONE                                       Date: 07/21/03    
Route: DOSED FEED                                                                                                 Time: 15:17:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        312 PPM      625 PPM      1250 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Respiratory Epithelium, Hyperplasia              1 (2%)                    1 (2%)                                             
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Inflammation                                     2 (4%)       1 (2%)       8 (16%)      3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (50)         (50)         (50)         (50)                                   
      Anterior Chamber, Inflammation                                                          1 (2%)                                
      Ciliary Body, Inflammation                                                 1 (2%)                                             
      Cornea, Inflammation                                                                    1 (2%)                                
      Iris, Fibrosis                                   1 (2%)                    1 (2%)                                             
      Iris, Inflammation                               1 (2%)                                 1 (2%)                                
      Lens, Cataract                                   2 (4%)                    1 (2%)                                             
      Lens, Mineralization                             1 (2%)                                                                       
      Retina, Atrophy                                  1 (2%)                                                                       
      Retina, Degeneration                             5 (10%)      2 (4%)       5 (10%)                                            
   Harderian Gland                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)                    1 (2%)       1 (2%)                                
      Infiltration Cellular, Lymphoid                  9 (18%)      4 (8%)       9 (18%)      3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Accumulation, Hyaline Droplet                    4 (8%)       1 (2%)       4 (8%)       2 (4%)                                
      Hyperplasia, Oncocytic                                                     1 (2%)                                             
      Infarct                                          1 (2%)       3 (6%)                                                          
      Nephropathy                                     50 (100%)    45 (90%)     50 (100%)    50 (100%)                              
      Artery, Inflammation                                                                    1 (2%)                                
      Cortex, Mineralization                                        1 (2%)       4 (8%)      14 (28%)                               
      Medulla, Mineralization                         47 (94%)     49 (98%)     47 (94%)     49 (98%)                               
      Papilla, Transitional Epithelium, Hyperplasia                                           1 (2%)                                
      Pelvis, Inflammation                                                       1 (2%)       1 (2%)                                
      Pelvis, Transitional Epithelium, Hyperplasia     1 (2%)      11 (22%)     29 (58%)     34 (68%)                               
      Renal Tubule, Cyst                                                         1 (2%)       9 (18%)                               
      Renal Tubule, Hyperplasia                        1 (2%)       5 (10%)     20 (40%)     23 (46%)                               
      Renal Tubule, Pigmentation                       1 (2%)       1 (2%)       2 (4%)                                             
   Urinary Bladder                                    (50)         (50)         (50)         (50)                                   
      Calculus Gross Observation                                    1 (2%)       1 (2%)                                             
      Inflammation                                     3 (6%)                    2 (4%)       2 (4%)                                
      Muscularis, Degeneration                         1 (2%)                                                                       
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   15                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------